<?xml version="1.0" encoding="UTF-8"?>
<list>
  <sentences>
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/plos/pmed.0020249.anc" start="11044" end="11051" sStart="-1" offset="0" sid="null" wn="5" wnkey="write%2:36:01::" text="To simulate repeated low-dose challenges in the vaccinated group, we perform repeated Bernoulli trials with a probability of success p v . For a given vaccine efficacy VE S , p v is determined by equation 3. Analogously to the control group, the results of these repeated Bernoulli trials can be &lt;b&gt;written&lt;/b&gt; as two vectors, " />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/plos/pmed.0020249.anc" start="11044" end="11051" sStart="null" offset="0" sid="null" wn="7" wnkey="write%2:36:03::" text="To simulate repeated low-dose challenges in the vaccinated group, we perform repeated Bernoulli trials with a probability of success p v . For a given vaccine efficacy VE S , p v is determined by equation 3. Analogously to the control group, the results of these repeated Bernoulli trials can be &lt;b&gt;written&lt;/b&gt; as two vectors, " />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/plos/pmed.0020249.anc" start="9865" end="9872" sStart="null" offset="0" sid="null" wn="5" wnkey="write%2:36:01::" text="The results of these repeated Bernoulli trials can be &lt;b&gt;written&lt;/b&gt; as two vectors, " />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/plos/pmed.0020249.anc" start="11044" end="11051" sStart="null" offset="0" sid="null" wn="7" wnkey="write%2:36:03::" text="To simulate repeated low-dose challenges in the vaccinated group, we perform repeated Bernoulli trials with a probability of success p v . For a given vaccine efficacy VE S , p v is determined by equation 3. Analogously to the control group, the results of these repeated Bernoulli trials can be &lt;b&gt;written&lt;/b&gt; as two vectors, " />
    <s path="[OANC]/data/written_2/technical/plos/pmed.0020249.anc" start="2636" end="2641" sStart="null" offset="34" sid="null" wn="1" wnkey="use%2:34:01::" text="There are, however, concerns with using high challenge doses." />
    <s path="[OANC]/data/written_2/technical/plos/pmed.0020249.anc" start="2636" end="2641" sStart="null" offset="34" sid="null" wn="1" wnkey="use%2:34:01::" text="There are, however, concerns with using high challenge doses." />
    <s path="[OANC]/data/written_2/technical/plos/pmed.0020249.anc" start="2636" end="2641" sStart="null" offset="34" sid="null" wn="1" wnkey="use%2:34:01::" text="There are, however, concerns with using high challenge doses." />
    <s path="[OANC]/data/written_2/technical/plos/pmed.0020249.anc" start="2636" end="2641" sStart="null" offset="34" sid="null" wn="1" wnkey="use%2:34:01::" text="There are, however, concerns with using high challenge doses." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/plos/pmed.0020249.anc" start="10801" end="10808" sStart="null" offset="0" sid="null" wn="2" wnkey="success%1:04:00::" text="To simulate repeated low-dose challenges in the vaccinated group, we perform repeated Bernoulli trials with a probability of &lt;b&gt;success&lt;/b&gt; p v . For a given vaccine efficacy VE S , p v is determined by equation 3. Analogously to the control group, the results of these repeated Bernoulli trials can be written as two vectors, " />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/plos/pmed.0020249.anc" start="10801" end="10808" sStart="null" offset="0" sid="null" wn="1" wnkey="success%1:11:00::" text="To simulate repeated low-dose challenges in the vaccinated group, we perform repeated Bernoulli trials with a probability of &lt;b&gt;success&lt;/b&gt; p v . For a given vaccine efficacy VE S , p v is determined by equation 3. Analogously to the control group, the results of these repeated Bernoulli trials can be written as two vectors, " />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/plos/pmed.0020249.anc" start="6904" end="6911" sStart="null" offset="0" sid="null" wn="1" wnkey="success%1:11:00::" text="The probability of &lt;b&gt;success&lt;/b&gt; corresponds to the probability with which an animal becomes infected after a single challenge." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/plos/pmed.0020249.anc" start="6842" end="6849" sStart="null" offset="0" sid="null" wn="1" wnkey="success%1:11:00::" text="In the control group, we simulate single challenges of each animal with the ID 50 by performing n Bernoulli trials with a probability of &lt;b&gt;success&lt;/b&gt; of p c = 0.5." />
  </sentences>
</list>